Using public clinical data, the Kaplan-Meier survival analysis found that ZBTB46, one of these 11 genes, is associated with a higher survival rate among lung cancer patients than those with low levels, implying that ZBTB46 expression may be associated with lung cancer protection. This evidence concerns the gene ZBTB46 and lung cancer.